Onderzoeker
Martijn Risseeuw
- Disciplines:Medicinale chemie, Farmacognosie en fytochemie, Farmaceutica, Ontdekking en evaluatie van biomarkers, Andere farmaceutische wetenschappen, Toxicologie en toxinologie, Farmacotherapie, Farmacologie, Small molecules, Klinische trials
Affiliaties
- Vakgroep Geneesmiddelenleer (Departement)
Lid
Vanaf1 jan 2010 → Heden
Projecten
1 - 1 of 1
- Efficiente zuivering van biologisch actieve small molecules en/of hun PEG conjugaten met behulp van geautomatiseerde Preparatieve HPLCVanaf1 jun 2015 → 31 mei 2017Financiering: BOF - Andere acties
Publicaties
1 - 10 van 69
- Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents(2023)
Auteurs: Charlotte Courtens, Frits van Charante, Thibaut Quennesson, Martijn Risseeuw, Paul Cos, Guy Caljon, Tom Coenye, Serge Van Calenbergh
- Targeted AURKA degradation : towards new therapeutic agents for neuroblastoma(2023)
Auteurs: Muhammad Rishfi, Simon Krols, Fien Martens, Sarah-Lee Bekaert, Aline Eggermont, Fanny De Vloed, Joshua Robert Goulding, Martijn Risseeuw, Jan Molenaar
- Report on a new opioid NPS : chemical and in vitro functional characterization of a structural isomer of the MT-45 derivative diphenpipenol(2021)
Auteurs: Annelies Cannaert, Fabian Hulpia, Martijn Risseeuw, Katleen Van Uytfanghe, Eric Deconinck, Peter Blanckaert
Pagina's: 134 - 140 - 2-((3,5-Dinitrobenzyl)thio)quinazolinones : potent antimycobacterial agents activated by deazaflavin (F420)-dependent nitroreductase (Ddn)(2021)
Auteurs: Yanlin Jian, He Eun Forbes, Fabian Hulpia, Martijn Risseeuw, Guy Caljon, Hélène Munier-Lehmann, Helena I. M. Boshoff
Pagina's: 440 - 457 - RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia(2021)
Auteurs: Filip Matthijssens, Nitesh D. Sharma, Monique Nysus, Christian K. Nickl, Huining Kang, Dominique R. Perez, Wouter Van Loocke, Sofie Peirs, Lindy Reunes, Filip Van Nieuwerburgh, et al.
- Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors(2021)
Auteurs: Lijun Song, Romain Merceron, Fabian Hulpia, Ainhoa Lucia, Begona Gracia, Yanlin Jian, Martijn Risseeuw, Toon Verstraelen, Paul Cos, Jose A. Ainsa, et al.
- Synthetic rhamnose glycopolymer cell-surface receptor for endogenous antibody recruitment(2020)
Auteurs: Ruben De Coen, Lutz Nuhn, Chamani Perera, Maria Arista-Romero, Martijn Risseeuw, Alec Freyn, Raffael Nachbagauer, Lorenzo Albertazzi, David A. Spiegel, Blake R. Peterson, et al.
Pagina's: 793 - 802 - Endeavors towards transformation of M. tuberculosis thymidylate kinase (MtbTMPK) inhibitors into potential antimycobacterial agents(2020)
Auteurs: Yanlin Jian, Romain Merceron, Steven De Munck, He Eun Forbes, Fabian Hulpia, Martijn Risseeuw, Kristof Van Hecke, Savvas Savvides, Hélène Munier-Lehmann, Helena I. M. Boshoff
- Synthesis and structure activity relationships of cyanopyridone based anti-tuberculosis agents(2020)
Auteurs: Yanlin Jian, Fabian Hulpia, Martijn Risseeuw, He Eun Forbes, Hélène Munier-Lehmann, Guy Caljon, Helena I. M. Boshoff, Serge Van Calenbergh
- 1-(1-Arylethylpiperidin-4-yl)thymine analogs as antimycobacterial TMPK inhibitors(2020)
Auteurs: Yanlin Jian, Fabian Hulpia, Martijn Risseeuw, He Eun Forbes, Guy Caljon, Hélène Munier-Lehmann, Helena I. M. Boshoff, Serge Van Calenbergh
Patenten
1 - 3 van 3
- HAMAMELITANNIN ANALOGUES AND USES THEREOF (Inventor)
- HAMAMELITANNIN ANALOGUES AND USES THEREOF (Inventor)
- NOVEL HAMAMELITANNIN ANALOGUES AND USES THEREOF (Inventor)